© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
CORRESPONDENCE |
Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
Correspondence to: Carl D. Atkins, MD, South Shore HematologyOncology Associates, 242 Merrick Rd., Ste. 301, Rockville Centre, NY 11570-5254 (e-mail: c3atkins@optonline.net)
| The first 10% of the full text of this article appears below. |
The new American Joint Committee on Cancer (AJCC) staging system for breast cancer correctly recognizes that small clusters of malignant cells do not confer the same adverse prognostic impact as larger metastatic deposits (1). The AJCCs decision to place
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 1639-1640.